罗欣药业: 关于为控股子公司提供担保的进展公告

Summary of Key Points Core Viewpoint - The company, 罗欣药业, is providing a guarantee for its subsidiary, 山东罗欣, to secure a bank credit line of 860 million RMB, which raises the total guarantee amount to 1,144.82 million RMB, indicating a significant commitment to support its subsidiary's operations and growth [1][2]. Group 1: Guarantee Overview - The company plans to provide a guarantee of 860 million RMB for its subsidiary, 山东罗欣, to meet operational and expansion funding needs [1]. - The total guarantee amount for 山东罗欣 before this new guarantee was 1,050.82 million RMB, which will increase to 1,144.82 million RMB after this transaction [2]. Group 2: Financial Status of the Subsidiary - 山东罗欣 is not a dishonored debtor and has a good credit status, with normal operational activities [2]. - The financial data for 山东罗欣 shows total assets of 4,972.40 million RMB, total liabilities of 2,756.94 million RMB, and net assets of 2,215.47 million RMB for the year 2024 [4]. Group 3: Board's Opinion - The board believes that providing this guarantee will enhance financing efficiency and reduce costs, ensuring normal operations for both the company and its subsidiary [5]. - The company maintains effective control over 山东罗欣, which is expected to manage its operations well, thus keeping the risks associated with the guarantee within a controllable range [5]. Group 4: Total Guarantee Amount - After this guarantee, the total guarantee amount by the company and its subsidiaries will be 2,538 million RMB, which is 183.61% of the latest audited net assets [6]. - The total balance of external guarantees after this transaction will be 1,178.22 million RMB, accounting for 85.24% of the latest audited net assets [6].